Botulinum Toxin type A (intradermal / submucosal injection at pain area)
FAHZU-2017-025
Phase 3 small_molecule active
Quick answer
Botulinum Toxin type A (intradermal / submucosal injection at pain area) for Trigeminal Neuralgia is a Phase 3 program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Trigeminal Neuralgia
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active